INNOVA CAPTAB Financial Statement Analysis
|
||
|
The Revenues of INNOVA CAPTAB have increased by 15.02% YoY .
The Earnings Per Share (EPS) of INNOVA CAPTAB has increased by 35.90 % YoY. |
||
INNOVA CAPTAB Last 5 Annual Financial Results
[BOM: 544067|NSE : INNOVACAP]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,244 Cr | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr |
| Expenses | ₹1,058 Cr | ₹927 Cr | ₹813 Cr | ₹705 Cr | ₹356 Cr |
| Operating Profit (Excl OI) | ₹186 Cr | ₹154 Cr | ₹114 Cr | ₹96 Cr | ₹54 Cr |
| Other Income | ₹12 Cr | ₹12 Cr | ₹9.20 Cr | ₹2.88 Cr | ₹1.37 Cr |
| Interest | ₹2.41 Cr | ₹21 Cr | ₹20 Cr | ₹5.68 Cr | ₹3.93 Cr |
| Depreciation | ₹25 Cr | ₹16 Cr | ₹11 Cr | ₹7.50 Cr | ₹5.59 Cr |
| Profit Before Tax | ₹171 Cr | ₹130 Cr | ₹92 Cr | ₹86 Cr | ₹46 Cr |
| Profit After Tax | ₹128 Cr | ₹94 Cr | ₹68 Cr | ₹64 Cr | ₹35 Cr |
| Consolidated Net Profit | ₹128 Cr | ₹94 Cr | ₹68 Cr | ₹64 Cr | ₹34 Cr |
| Earnings Per Share (Rs) | ₹22.41 | ₹16.49 | ₹14.16 | ₹531.54 | ₹286.86 |
| PAT Margin (%) | 10.13 | 8.71 | 7.23 | 7.91 | 8.38 |
| ROE(%) | 14.33 | 17.04 | 28.02 | 36.19 | 27.04 |
| ROCE(%) | 14.65 | 19.06 | 24.34 | 30.64 | 28.42 |
| Total Debt/Equity(x) | 0.35 | 0.29 | 0.85 | 0.95 | 0.31 |
Key Financials |
||
| Market Cap | : | ₹ 4,932.4 Cr |
| Revenue (TTM) | : | ₹ 1,630.0 Cr |
| Net Profit(TTM) | : | ₹ 140.9 Cr |
| EPS (TTM) | : | ₹ 24.6 |
| P/E (TTM) | : | 35.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INNOVA CAPTAB | 0.2% | -1.5% | -0.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -3.6% | 6% |
| DIVIS LABORATORIES | 1.1% | -1.2% | -0.3% |
| TORRENT PHARMACEUTICALS | 1.6% | 1.4% | 36.7% |
| CIPLA | 0.7% | 2.6% | -4.6% |
| DR REDDYS LABORATORIES | -0.9% | -2.5% | 1.2% |
| MANKIND PHARMA | 0.7% | -1.1% | -4.8% |
| LUPIN | 0.4% | -7.1% | 14.8% |
| ZYDUS LIFESCIENCES | -0.2% | 16% | 16.7% |
INNOVA CAPTAB Revenues
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 15.02 % |
| 5 Yr CAGR | 31.92 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,244 Cr | 15.02 | |
| Mar2025 | ₹1,081 Cr | 16.72 | |
| Mar2024 | ₹926 Cr | 15.72 | |
| Mar2023 | ₹801 Cr | 94.94 | |
| Mar2022 | ₹411 Cr | - | |
INNOVA CAPTAB Operating Profit
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 20.53 % |
| 5 Yr CAGR | 35.96 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹186 Cr | 20.53 | |
| Mar2025 | ₹154 Cr | 35.91 | |
| Mar2024 | ₹114 Cr | 18.36 | |
| Mar2023 | ₹96 Cr | 76.23 | |
| Mar2022 | ₹54 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 4.83 % |
| 5 Yr CAGR | 3.06 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 14.97% | 4.83 | |
| Mar2025 | 14.28% | 16.38 | |
| Mar2024 | 12.27% | 2.34 | |
| Mar2023 | 11.99% | -9.65 | |
| Mar2022 | 13.27% | - | |
INNOVA CAPTAB Profit After Tax
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 35.95 % |
| 5 Yr CAGR | 38.93 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹128 Cr | 35.95 | |
| Mar2025 | ₹94 Cr | 38.84 | |
| Mar2024 | ₹68 Cr | 6.54 | |
| Mar2023 | ₹64 Cr | 85.30 | |
| Mar2022 | ₹34 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 16.30 % |
| 5 Yr CAGR | 4.86 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 10.13 % | 16.30 | |
| Mar2025 | 8.71 % | 20.47 | |
| Mar2024 | 7.23 % | -8.60 | |
| Mar2023 | 7.91 % | -5.61 | |
| Mar2022 | 8.38 % | - | |
INNOVA CAPTAB Earnings Per Share (EPS)
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | 35.90 % |
| 5 Yr CAGR | -47.13 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹22 | 35.90 | |
| Mar2025 | ₹16 | 16.45 | |
| Mar2024 | ₹14 | -97.34 | |
| Mar2023 | ₹532 | 85.30 | |
| Mar2022 | ₹287 | - | |
INNOVA CAPTAB Return on Capital Employed (ROCE)
[BOM: 544067|NSE : INNOVACAP]
| Y-o-Y | -23.14 % |
| 5 Yr CAGR | -15.27 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 14.65% | -23.14 | |
| Mar2025 | 19.06% | -21.69 | |
| Mar2024 | 24.34% | -20.56 | |
| Mar2023 | 30.64% | 7.81 | |
| Mar2022 | 28.42% | - | |
INNOVA CAPTAB Share Price vs Sensex
| Current Share Price | : | ₹862.3 |
| Current MarketCap | : | ₹ 4,932.4 Cr |
| Updated EOD on | : | Jun 05,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 0.2% |
-1.5% |
-0.6% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
INNOVA CAPTAB related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.2% | 3.5% | 9.8% |
| BSE 1000 | -0.7% | -1.3% | -1.9% |
No NSE index found
You may also like the below Video Courses
FAQ about INNOVA CAPTAB Financials
How the annual revenues of INNOVA CAPTAB have changed ?
The Revenues of INNOVA CAPTAB have increased by 15.02% YoY .
How the Earnings per Share (EPS) of INNOVA CAPTAB have changed?
The Earnings Per Share (EPS) of INNOVA CAPTAB has increased by 35.90 % YoY .
Check out Intrinsic Value of Peers of INNOVA CAPTAB
Compare Stock Analytics of Peers of INNOVA CAPTAB
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
